Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022

Latest Articles

  • You have access
    Outcomes studies of the gastrointestinal safety of cyclooxygenase-2 inhibitors
    James M. Scheiman, MD
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 1) SI-40-SI-46;
  • You have access
    Sinonasal complications of vasculitic diseases
    Robert S. Lebovics, MD, FACS
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-152-SII-154;
  • You have access
    Campath 1-H (Anti-CD52) for Refractory Vasculitis: Retrospective Cambridge Experience 1989–1999
    DRW Jayne
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-129;
  • You have access
    Kawasaki disease: Etiology, pathogenesis, and treatment
    Karyl S. Barron, MD
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-69-SII-78;
  • You have access
    Corrections
    Cleveland Clinic Journal of Medicine April 2002, 69 (4) 273;

    Xigris dosage, order of authors.

  • You have access
    Pathogenesis—Possible Role of ANCA and AECA in Selected Forms of Systemic Vasculitis
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-160-SII-165;
  • A 52-year-old man with excessive daytime sleepiness
    You have access
    A 52-year-old man with excessive daytime sleepiness
    Bipin D. Sarodia, MD, Reena Mehra, MD and Joseph A. Golish, MD
    Cleveland Clinic Journal of Medicine March 2002, 69 (3) 193-207;

    What is the cause of this patient’s symptoms? A self-test.

  • You have access
    What is the best way to determine if thrombocytopenia in a patient on multiple medications is drug-induced?
    Navneet S. Majhail, MD and Alan E. Lichtin, MD
    Cleveland Clinic Journal of Medicine March 2002, 69 (3) 259-262;

    The only way is to stop the suspected drug and see if the thrombocytopenia resolves. But how to avoid stopping needed drugs that are not a problem?

  • You have access
    How to use nesiritide in treating decompensated heart failure
    Roger M. Mills, MD and Robert E. Hobbs, MD
    Cleveland Clinic Journal of Medicine March 2002, 69 (3) 252-256;

    Nesiritide, a recombinant formulation of BNP, is the first new parenteral drug in more than a decade to be approved for treating heart failure.

  • You have access
    How to assess and counsel the older driver
    Barbara J. Messinger-Rapport, MD, PhD
    Cleveland Clinic Journal of Medicine March 2002, 69 (3) 184-192;

    Suggesting that a patient stop driving is never easy, yet taking no action may have deadly consequences.

Pages

  • Previous
  • Next
  • 1
  • …
  • 391
  • 392
  • 393
  • 394
  • 395
  • 396
  • 397
  • 398
  • 399
  • …
  • 799

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire